Michael Baumann, MD
@_MichaelBaumann
Followers
2K
Following
5K
Media
47
Statuses
3K
Scientific Chair and CEO German Cancer Research Center @DKFZ; Physician Scientist RadOnc; Professor; tweets = personal views
Heidelberg
Joined October 2013
Congratulations- great achievement!
Daniel Kirschenbaum has developed an experimental method for investigating immune responses in living organisms with high temporal resolution. For this he received the Langen Science Prize, worth €15,000. 👏 @PEI_Germany @Stadt_Langen
https://t.co/mYwqdjMjuK
0
0
2
Great achievement David - and so well deserved!
🎉A massive congratulations to #RMPatPM’s @DKirschMDPhD on receiving @CureSarcoma’s 2025 Nobility in Science award, which honours visionary leaders in sarcoma research. Dr. Kirsch was presented with the award at the annual Stand Up to Sarcoma Gala last week.
3
0
3
🎉A massive congratulations to #RMPatPM’s @DKirschMDPhD on receiving @CureSarcoma’s 2025 Nobility in Science award, which honours visionary leaders in sarcoma research. Dr. Kirsch was presented with the award at the annual Stand Up to Sarcoma Gala last week.
0
8
33
@HenningWillers @_MichaelBaumann @RRS_RadRes @JulieSchwarz14 @DKirschMDPhD @bradwouters @DKFZ @KrauseProf @DKTK_ @NickiSimone4 @SMarkovina2 Herman’s large footprint have marked radiation oncology forever Congratulation with the honor Michael
0
1
5
Since their discovery in 2004, the grid cells in the brain have been regarded as a kind of "GPS in the head." However, scientists at DKFZ and @uniklinik_hd have now shown that grid cells work much more flexibly than previously assumed. @NatureNeuro
https://t.co/7AndI5Ezno
dkfz.de
Since their discovery in 2004, the grid cells in the brain, which are important for our orientation, have been regarded as a kind of “GPS in the head.” However, scientists at the German Cancer...
0
2
2
We are on our way!
Good morning #PuertoRico #RadRes2025🌄 Exciting meeting with lots of new things‼️ ✅️Lanyard ribbons for the first time🥳 with a bunch of fun ones as well😅 ✅️SIT Poster Slam today💪
0
0
3
An aspirin a day keeps the medical oncologist away? ALASCCA made waves at GI ASCO 🌊 when it showed that a cheap, widely available drug—low-dose aspirin—can meaningfully reduce recurrence risk in a genomically selected subset of colorectal cancer. This randomized,
nejm.org
Aspirin reduces the incidence of colorectal adenoma and colorectal cancer among high-risk persons. Observational studies suggest that aspirin may also improve disease-free survival after diagnosis,...
3
22
61
Super important research for advancing primary prevention, early detection and interception of disease!
Scientists from @embl and DKFZ have developed an AI model that assesses the long-term individual risk for more than 1,000 diseases. The model can predict health events over a period of more than a decade. @MoritzGerstung @Nature
https://t.co/7rljF35GIa
0
1
6
I feel deeply honored to receive the 2025 Dr. Josef Steiner Cancer Research Award for our work on decoding and rewiring the immune-evasive TME. It truly is a recognition of the entire team past and present as well as our collaborators and my mentors.🙌 Thank you for your trust.
Congratulations to our @obenaufa on receiving the highly prestigious Dr. Josef Steiner Cancer Research Award 2025! 🎉 Read more in this interview with Anna: https://t.co/qeE2eVWQjG
31
16
214
Fighting #cancer with compassion and precision: we celebrate World Radiotherapy Awareness Day (WRAD). Listen to PD Dr. Fabian Weykamp's video statement! ➡️ More Info: https://t.co/1uHibhhF2O
#WRAD #WorldRTDay
0
1
3
Visiting #Zambia, providing technical support for soon to open radiotherapy center at Cancer Diseases Hospital in Lusaka. #endcancer #radonc @MDAndersonNews @kmschmeler
2
2
36
Der Anteil der Rauchenden in 🇩🇪 sinkt seit Jahren stetig. Dennoch raucht in D weiterhin jede vierte erwachsene Person. Besonders hoch ist der Anteil bei den 18- bis 29-Jährigen: Über 40% der ♂️ und rund 30% der ♀️ rauchen. 👉Mehr #FaktenUnvernebelt hier: https://t.co/pcpcrX9Qyj
1
1
1
Chordomas are rare bone tumors for which there are currently no effective drugs. A research team from the DKFZ and @NCT_HD managed to block the central driver of tumor development and in the result slowed the growth of chordoma cells. https://t.co/Qdyxj9KuHE
dkfz.de
Chordomas are rare bone tumors for which there are currently no effective drugs. A research team from the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT)...
1
2
3
Researchers from DKFZ and @UniHeidelberg developed a therapeutic vaccination concept against #HPV-related tumors that can mobilize the immune system to target #cancer cells with the help of silica nanoparticles. https://t.co/Uv8e3zoTxm
dkfz.de
Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the...
0
3
5
Rauchen verursacht rund 85 % aller Lungenkrebserkrankungen. Etwa jeder 7. Todesfall in D ist auf das Rauchen zurückzuführen. Allein im Jahr 2023 waren es rund 131.000 Todesfälle. #Krebspräventionswoche #Faktenunvernebelt
https://t.co/xPMZC6eafa
1
2
3
Chordome sind seltene Knochentumoren, gegen die es bislang keine wirksamen Medikamente gibt. Forschende vom DKFZ und @NCT_HD konnten nun gezielt den zentralen Treiber der Tumorentstehung blockieren und dadurch das Wachstum von Chordomzellen bremsen. https://t.co/UVnILe8q6t
dkfz.de
Chordome sind seltene Knochentumoren, gegen die es bislang keine wirksamen Medikamente gibt. Ein Forschungsteam vom Deutschen Krebsforschungszentrum (DKFZ) und vom Nationalen Centrum für Tumorerkra...
0
3
6
Jeder siebte Todesfall ist eine Folge des Rauchens - Mit der Neuauflage des #Tabakatlas Deutschland stellen das DKFZ und die Deutsche Krebshilfe eine Zusammenfassung aktueller Daten und Fakten rund um den Tabakkonsum zur Verfügung. @BMG_Bund
https://t.co/PAu4lLtJVE
5
4
11
Warum ist #Tabakkontrolle so schwierig? Im Interview spricht SPD-Politiker @Lothar_Binding über den politischen Handlungsbedarf und die Herausforderungen der Tabakkontrolle. Den kompletten Beitrag gibt's hier: https://t.co/pcpcrX9Qyj
#FaktenUnvernebelt
@BMG_Bund
1
1
1
Eine neue Studie des DKFZ und der BARMER Krankenversicherung zeigt, dass die Nutzung der #Darmkrebs|früherkennung in Deutschland weit hinter den Möglichkeiten zurückbleibt. @BARMER_Presse #Krebsprävention https://t.co/uKvk3mh6iA
dkfz.de
Nur ein kleiner Bruchteil der anspruchsberechtigten Bevölkerung nutzt das Darmkrebs-Früherkennungsangebot, zeigt eine neue Studie des Deutschen Krebsforschungszentrums (DKFZ) und der BARMER Kranken...
0
1
4
So well deserved!!!
Michaela Frye, Leiterin der Abteilung "Regulatorische Mechanismen der Genexpression" am DKFZ, erhält den GSCN 2025 Hilde Mangold Award für ihre herausragenden Leistungen als Stammzellforscherin und ihre Vorbildrolle als exzellente Wissenschaftlerin. 👏 @gscn_office
0
0
0